Encyclopedia of Law and Economics

2019 Edition
| Editors: Alain Marciano, Giovanni Battista Ramello

Human Experimentation

  • Roberto IppolitiEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-7753-2_237

Abstract

Human experimentations refer to medical investigations with humans involved as experimental subjects. These trials are prospective researches aimed at answering specific questions about biomedical interventions, generating safety and efficacy data on drugs and treatments, innovative devices or novel vaccines, as well as new ways of using known interventions.

After a brief introduction of human experimentations, this section presents the main related issues in Law and Economics, i.e., the risk sharing between society and pharmaceutical industry.

This is a preview of subscription content, log in to check access.

References

  1. Criscuolo P (2005) On the road again: researcher mobility inside the R&D network. Res Policy 34:1350–1365CrossRefGoogle Scholar
  2. Ippoliti R (2013) The market of human experimentation. Eur J Law Econ 35(1):61–85CrossRefGoogle Scholar
  3. LEEM report (2008) L’industrie du médicament en France, réalités économiques Les Entreprises du Médicament (LEEM), 2008 edn, Paris.Google Scholar
  4. The Association of the British Pharmaceutical Industry (1994) Clinical trial compensation guidelines. ABPI, LondonGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Management, University of TurinTurinItaly
  2. 2.Scientific Promotion, Hospital of Alessandria – “SS. Antonio e Biagio e Cesare Arrigo”AlessandriaItaly